Clinical trial
Compassionate Use of Opaganib in Patients With Severe COVID-19
NCT04435106 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compassionate Use of Opaganib in Patients With Severe COVID-19
- Lead sponsor
- Shaare Zedek Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 3, 2020
- Completion date
- May 15, 2020
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.